Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
K 114 (AC216)
Cat.#: ASSD-216
Specifications
Description K 114, a potent amyloid fibril-specific fluorescent dye, is similar to Congo Red. The product is used to recognize amyloid lesions and quantitative monitoring of the formation of amyloid fibrils assembled from the Aβ peptide, α-synuclein, and tau. Synonyms (trans,trans)-1-Bromo-2,5-bis-(4-hydroxy)styrylbenzene; K114 Size 10 mg, 50 mg Applications Potent amyloid fibril-specific fluorescent dye Molecule Weight 393.27 Molecular formula C22H17BrO2 CAS Number 872201-12-2 MDL Number MFCD11045294 Purity ≥98% Solubility Soluble in DMSO (100 mM ), and ethanol (50 mM ). Storage Store at 4° C Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-151 Acid Fuchsin (AC151) 25 g inquiry ASSD-153 Brilliant Blue G (AC153) 1g inquiry ASSD-172 Ionomycin free acid (AC172) 1mg, 5mg inquiry ASSD-189 7-Hydroxycoumarin-3-carboxylic acid (AC189) 100 mg inquiry ASSD-111 Propidium Iodide (AC111) 10 mg, 50 mg inquiry ASSD-202 5(6)-Carboxytetramethylrhodamine (AC202) 100 mg, 250 mg inquiry ASSD-114 Acridine Orange hydrochloride (AC114) 50 mg inquiry ASSD-127 Fluorescent H3 antagonist [clobenpropit] (AC127) 50 μg inquiry ASSD-179 8-Azidoadenosine-5′-diphosphate Sodium Salt (AC179) 1 mg, 5 mg inquiry ASSD-186 Bromocresol Purple (AC186) 5 g, 10 g inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket